DBV Technologies (DBVT) Goodwill & Intangibles (2015 - 2026)
DBV Technologies (DBVT) posted Goodwill & Intangibles of $100000.0 for Q1 2026, up 376.19% sequentially from $21000.0 in Q3 2025, and up 244.83% YoY from $29000.0 in Q1 2025.
Analysis
DBV Technologies (DBVT) Goodwill & Intangibles (2015 - 2026) Analysis & Trends
DBV Technologies has reported Goodwill & Intangibles for 12 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Goodwill & Intangibles rose 244.83% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 244.83% YoY) and the FY2024 annual result came in at $40000.0, down 31.03% from the prior year.
- Goodwill & Intangibles rose to $100000.0 in Q1 2026 per DBVT's latest filing, from $21000.0 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $100000.0 in Q1 2026 and troughed at $10000.0 in Q4 2022.
- A 5-year average of $37937.5 and a median of $34500.0 in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles sank 57.69% in 2022, then soared 480.0% in 2023.
- Over 5 years, Goodwill & Intangibles stood at $10000.0 in 2022, then jumped by 480.0% to $58000.0 in 2023, then sank by 31.03% to $40000.0 in 2024, then tumbled by 47.5% to $21000.0 in 2025, then soared by 376.19% to $100000.0 in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $100000.0, $21000.0, and $26000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | DBV Technologies | 5.88 Bn | 5.70 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 32,000.00 |